Consonance Capital Management LP 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:58 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 0 0.000% |
-470,344 (Position Closed) |
Filing |
| 2021-02-17 3:10 pm Sale |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 470,344 9.990% |
-135,507 (-22.37%) |
Filing |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 605,851 9.990% |
605,851 (New Position) |
Filing |